Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smit

Showing results (261-270 of 692) with videos related to

Pageof 70
Sort By:
Targeted Oncology|December 11, 2021
Representativeness of Phase III Trial for Osimertinib in Pretreated Advanced EGFR-Mutated Non-small-cell Lung Cancer Patients and Treatment Outcomes in Clinical PracticeLishi Lin, Egbert F Smit, Adrianus J de Langen, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|October 18, 2003
Guidance for the safety assessment of botanicals and botanical preparations for use in food and food supplementsB Schilter, C Andersson, R Anton, et al.
British Journal of Cancer|January 1, 1997
A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral bloodW Helfrich, R ten Poele, G J Meersma, et al.
The Netherlands Journal of Medicine|June 21, 2002
Failure patterns of combined modality treatment in lung cancer: the impact of stagingC J Hoekstra, H Rijna, E F Smit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Pemetrexed pathway-associated germline polymorphisms: a useful tool for treatment individualization?Wieneke A Buikhuisen, Jacobus A Burgers, Andrew D Vincent, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 4, 2004
The performance of( 18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodulesGerarda J Herder, Richard P Golding, Otto S Hoekstra, et al.
Journal of Medical Internet Research|February 6, 2014
Why do patients and caregivers seek answers from the Internet and online lung specialists? A qualitative studyRomane Milia Schook, Cilia Linssen, Franz Mnh Schramel, et al.
EJNMMI Research|February 5, 2019
Partial-volume correction in dynamic PET-CT: effect on tumor kinetic parameter estimation and validation of simplified metricsM C F Cysouw, S V S Golla, V Frings, et al.
International Journal of Radiation Oncology, Biology, Physics|November 23, 2011
Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancerFrank J Lagerwaard, Naomi E Verstegen, Cornelis J A Haasbeek, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2011
Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatmentA Becker, L Crombag, D A M Heideman, et al.
Pageof 70

Showing results (261-270 of 692) with videos related to

Sort By:
Pageof 70
Targeted Oncology|December 11, 2021
Representativeness of Phase III Trial for Osimertinib in Pretreated Advanced EGFR-Mutated Non-small-cell Lung Cancer Patients and Treatment Outcomes in Clinical PracticeLishi Lin, Egbert F Smit, Adrianus J de Langen, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|October 18, 2003
Guidance for the safety assessment of botanicals and botanical preparations for use in food and food supplementsB Schilter, C Andersson, R Anton, et al.
British Journal of Cancer|January 1, 1997
A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral bloodW Helfrich, R ten Poele, G J Meersma, et al.
The Netherlands Journal of Medicine|June 21, 2002
Failure patterns of combined modality treatment in lung cancer: the impact of stagingC J Hoekstra, H Rijna, E F Smit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Pemetrexed pathway-associated germline polymorphisms: a useful tool for treatment individualization?Wieneke A Buikhuisen, Jacobus A Burgers, Andrew D Vincent, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 4, 2004
The performance of( 18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodulesGerarda J Herder, Richard P Golding, Otto S Hoekstra, et al.
Journal of Medical Internet Research|February 6, 2014
Why do patients and caregivers seek answers from the Internet and online lung specialists? A qualitative studyRomane Milia Schook, Cilia Linssen, Franz Mnh Schramel, et al.
EJNMMI Research|February 5, 2019
Partial-volume correction in dynamic PET-CT: effect on tumor kinetic parameter estimation and validation of simplified metricsM C F Cysouw, S V S Golla, V Frings, et al.
International Journal of Radiation Oncology, Biology, Physics|November 23, 2011
Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancerFrank J Lagerwaard, Naomi E Verstegen, Cornelis J A Haasbeek, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2011
Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatmentA Becker, L Crombag, D A M Heideman, et al.
Pageof 70